Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 18Terminated 3Active not recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Sarcoma 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Rhabdoid Tumor 1Neoplasms, Squamous Cell 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Adult Solid Neoplasm 1

Interventions

pembrolizumab 46Cisplatin 29Carboplatin 19Cetuximab 16Nivolumab 15Paclitaxel 14Radiotherapy, Intensity-Modulated 12Docetaxel 10Radiotherapy 9Fluorouracil 9Platinum 8durvalumab 7Taxes 71,2-diaminocyclohexaneplatinum II citrate 7Radiation 6tislelizumab 5Magnetic Resonance Spectroscopy 5Albumin-Bound Paclitaxel 5cemiplimab 4avelumab 4Specimen Handling 4Radiosurgery 4Drug Therapy 4Biopsy 4130-nm albumin-bound paclitaxel 4tremelimumab 3palbociclib 3olaparib 3Interleukin-2 3zimberelimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Squamous Cell Carcinoma of Head and Neck × Erlotinib Hydrochloride × Clear all
NCT00076310 2026-04-15

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled 11 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms, Squamous Cell

NCT05827614 2026-01-23

POTENTIATE

Boundless Bio, Inc.

Phase 1 Active not recruiting
85 enrolled
BreastHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Leiomyosarcoma, Histiocytoma, Malignant Fibrous, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡